Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2001

View Archived Issues

Active Biotech updates development programs

Exisulind may delay disease progression in prostate cancer patients

Copaxone reduces the percentage of permanent "black holes" in MS

Raven Biotechnologies delivers first MAb to ImmunoGen in ovarian cancer research collaboration

Matrix to seek E.U. approval of IntraDose by Q4 2001

Myriad Genetics uncovers potential of MPI-176716 as broad-spectrum cancer treatment

VaxGen receives further funding from NIH for HIV vaccine development

PLG microsphere formulation of human beta-amyloid(1-42) induces significant serum antibody response

Lorus and Faulding establish Virulizin distribution agreement for Latin America

Licensing agreement announced for ramoplanin

Karo Bio updates KB-002611 clinical development

Platinum complexes simultaneously targeting DNA and thioredoxin reductase

Positive data presented for OC-1016, a novel bone- and tissue-regenerating agent

Daiichi presents chemistry and pharmacology for diaminobutane AMPA receptor antagonists

3-Dimensional Pharmaceuticals to receive milestone payment for thrombin inhibitor program

Gene therapy for B-cell malignancies heading for phase II testing

Avigen's Coagulin-B gene therapy for hemophilia B trial on clinical hold

Phase II trial of Argatroban plus gpIIb/IIIa antagonists initiated in patients undergoing PCI

Fully humanized antibody for diagnosis and therapy of cancer

Rotta presents new leukotriene antagonists related to tyrosine

New nitroacridine derivatives with excellent in vivo antitumor activity

Inhibitors of PDE5 for sexual dysfunction and other disorders in development in Korea

Merck continues to identify inhibitors of protein prenyltransferases

Beta3-adrenoceptor agonists and use in urinary incontinence, obesity and diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...